Skip to content

The effect of progesterone in patients with premature rupture of membranes

The effect of progesterone in patients with premature rupture of membranes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201512077676N4
Enrollment
120
Registered
2016-04-06
Start date
2016-03-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature rupture of membranes, labour delayed by therapy. Premature rupture of membranes, labour delayed by therapy

Interventions

Intervention 1: Intervention group : progesterone ( 400 mg a daily intravaginal. Intervention 2: Control group: routine treatment includes injections of betamethasone 12 mg of progesterone administere
Treatment - Drugs
Intervention group : progesterone ( 400 mg a daily intravaginal
Control group: routine treatment includes injections of betamethasone 12 mg of progesterone administered every 12 hours

Sponsors

Vice Chancellor for Research and Technology University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 48 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: pregnant women with gestational age between 26 to 32 weeks with premature rupture of membranes (PROM); signing informed consent. Exclusion criteria: fetal abnormalities; genetic abnormalities that can affect fetal growth that have been checked by ultrasound at 18 to 20 weeks and 28 to 32 weeks. Along with trisomy screening marker with double or quad marker; precambrian patients; chronic high blood pressure; overt diabetes; pregnancy-related diabetes; detachment; prolapsed umbilical cord; chorioamnionitis; gestational age over 32 weeks (because there isn’t sufficient time to study the effects of progesterone); patient who have had a rupture of the membranes after 36 hours; patient who are in active phase.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lengthening the interval between the pre-term delivery runny. Timepoint: Daily. Method of measurement: Physical examination.

Secondary

MeasureTime frame
Improving Perinatal Outcomes. Timepoint: Follow baby daily until discharge. Method of measurement: Physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Simin Taghavi

Tabriz University of medical Sciences

lahroudin@gmail.com+98 41 3553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026